Teewinot is doing biosynthesis for several companies which is cost effective and fast. Other than GW, nobody is going to develop a drug using the plant. It won't get approved for one and it's too costly and inefficient for another. It seems that InMed is doing it differently but I have no idea if it's better or cheaper or faster. Perhaps others can shed light on it.
InMed intrigues me because there could be something there. I just can't tell if what they have has value. They're probably 2 years away from being able to make their drug and don't have any approved patents yet from what I can tell.
News 
Market Data 
Discover 
